4. Bogach J, Tsai S, Zbuk K, Wong R, Grubac V, Coates A, et al. Quality of preoperative pelvic computed tomography (CT) and magnetic resonance imaging (MRI) for rectal cancer in a region in Ontario: a retrospective population-based study. J Surg Oncol 2018;117:1038–42.
5. Zhou Y, Shao W, Lu W. Diagnostic value of endorectal ultrasonography for rectal carcinoma: a meta-analysis. J Cancer Res Ther 2014;10 Suppl:319–22.
7. Al-Sukhni E, Milot L, Fruitman M, Beyene J, Victor JC, Schmocker S, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol 2012;19:2212–23.
10. Kang SB, Park JW, Jeong SY, Nam BH, Choi HS, Kim DW, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): shortterm outcomes of an open-label randomised controlled trial. Lancet Oncol 2010;11:637–45.
11. Kim JY, Kim YW, Kim NK, Hur H, Lee K, Min BS, et al. Pelvic anatomy as a factor in laparoscopic rectal surgery: a prospective study. Surg Laparosc Endosc Percutan Tech 2011;21:334–9.
12. Kyo K, Sameshima S, Takahashi M, Furugori T, Sawada T. Impact of autonomic nerve preservation and lateral node dissection on male urogenital function after total mesorectal excision for lower rectal cancer. World J Surg 2006;30:1014–9.
13. Nakagoe T, Ishikawa H, Sawai T, Tsuji T, Tanaka K, Hidaka S, et al. Survival and recurrence after a sphincter-saving resection and abdominoperineal resection for adenocarcinoma of the rectum at or below the peritoneal reflection: a multivariate analysis. Surg Today 2004;34:32–9.
14. Nash GM, Weiss A, Dasgupta R, Gonen M, Guillem JG, Wong WD. Close distal margin and rectal cancer recurrence after sphincter-preserving rectal resection. Dis Colon Rectum 2010;53:1365–73.
15. Zeng WG, Liu MJ, Zhou ZX, Wang ZJ. A distal resection margin of ≤1 mm and rectal cancer recurrence after sphincter-preserving surgery: the role of a positive distal margin in rectal cancer surgery. Dis Colon Rectum 2017;60:1175–83.
16. Stelzner S, Holm T. Extralevator abdominoperineal excision. Coloproctology 2020;42:37–46.
17. Holm T, Ljung A, Häggmark T, Jurell G, Lagergren J. Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg 2007;94:232–8.
18. Miles WE. A method of performing abdomino-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. Lancet 1908;172:1812–3.
20. Kim TH, Jeong SY, Choi DH, Kim DY, Jung KH, Moon SH, et al. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol 2008;15:729–37.
21. Beets GL, Figueiredo NL, Habr-Gama A, van de Velde CJ. A new paradigm for rectal cancer: organ preservation. Introducing the International Watch & Wait Database (IWWD). Eur J Surg Oncol 2015;41:1562–4.
22. Choy KT, Yang T, Prabhakaran S, Heriot A, Kong JC, Warrier SK. Comparing functional outcomes between transanal total mesorectal excision (TaTME) and laparoscopic total mesorectal excision (LaTME) for rectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis 2021;36:1163–74.
23. Heald RJ. A new approach to rectal cancer. Br J Hosp Med 1979;22:277–81.
24. Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 2020;25:1–42.
25. Lowry AC, Simmang CL, Boulos P, Farmer KC, Finan PJ, Hyman N, et al. Consensus statement of definitions for anorectal physiology and rectal cancer: report of the Tripartite Consensus Conference on Definitions for Anorectal Physiology and Rectal Cancer, Washington, D.C., May 1, 1999. Dis Colon Rectum 2001;44:915–9.
26. Wibe A, Rendedal PR, Svensson E, Norstein J, Eide TJ, Myrvold HE, et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002;89:327–34.
27. Adam IJ, Mohamdee MO, Martin IG, Scott N, Finan PJ, Johnston D, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994;344:707–11.
28. Rullier E, Laurent C, Bretagnol F, Rullier A, Vendrely V, Zerbib F. Sphincter-saving resection for all rectal carcinomas: the end of the 2-cm distal rule. Ann Surg 2005;241:465–9.
29. Lindsey I, Guy RJ, Warren BF, Mortensen NJ. Anatomy of Denonvilliers’ fascia and pelvic nerves, impotence, and implications for the colorectal surgeon. Br J Surg 2000;87:1288–99.
30. Kong M, Chen H, Xin Y, Jiang Y, Han Y, Sheng H. High ligation of the inferior mesenteric artery and anastomotic leakage in anterior resection for rectal cancer: a systematic review and metaanalysis of randomized controlled trial studies. Colorectal Dis 2021;23:614–24.
31. Hajibandeh S, Hajibandeh S, Maw A. Meta-analysis and trial sequential analysis of randomized controlled trials comparing high and low ligation of the inferior mesenteric artery in rectal cancer surgery. Dis Colon Rectum 2020;63:988–99.
33. Lyttle JA, Parks AG. Intersphincteric excision of the rectum. Br J Surg 1977;64:413–6.
35. Fleshman JW, Wexner SD, Anvari M, LaTulippe JF, Birnbaum EH, Kodner IJ, et al. Laparoscopic vs. open abdominoperineal resection for cancer. Dis Colon Rectum 1999;42:930–9.
36. Wang HS, Lin JK, Yang SH, Jiang JK, Chen WS, Lin TC. Prospective study of the functional results of transanal endoscopic microsurgery. Hepatogastroenterology 2003;50:1376–80.
37. Neary P, Makin GB, White TJ, White E, Hartley J, MacDonald A, et al. Transanal endoscopic microsurgery: a viable operative alternative in selected patients with rectal lesions. Ann Surg Oncol 2003;10:1106–11.
38. Gavagan JA, Whiteford MH, Swanstrom LL. Full-thickness intraperitoneal excision by transanal endoscopic microsurgery does not increase short-term complications. Am J Surg 2004;187:630–4.
39. Lee W, Lee D, Choi S, Chun H. Transanal endoscopic microsurgery and radical surgery for T1 and T2 rectal cancer. Surg Endosc 2003;17:1283–7.
41. Jayne DG, Guillou PJ, Thorpe H, Quirke P, Copeland J, Smith AM, et al. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 2007;25:3061–8.
42. van der Pas MH, Haglind E, Cuesta MA, Fürst A, Lacy AM, Hop WC, et al. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 2013;14:210–8.
43. Fleshman J, Branda ME, Sargent DJ, Boller AM, George VV, Abbas MA, et al. Disease-free survival and local recurrence for laparoscopic resection compared with open resection of stage II to III rectal cancer: follow-up results of the ACOSOG Z6051 randomized controlled trial. Ann Surg 2019;269:589–95.
44. Stevenson A, Solomon MJ, Brown C, Lumley JW, Hewett P, Clouston AD, et al. Disease-free survival and local recurrence after laparoscopic-assisted resection or open resection for rectal cancer: the Australasian Laparoscopic Cancer of the Rectum randomized clinical trial. Ann Surg 2019;269:596–602.
45. Park JW, Kang SB, Hao J, Lim SB, Choi HS, Kim DW, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): 10-year follow-up of an open-label, non-inferiority, randomised controlled trial. Lancet Gastroenterol Hepatol 2021;6:569–77.
46. Kim JC, Lee JL, Alotaibi AM, Yoon YS, Kim CW, Park IJ. Robot-assisted intersphincteric resection facilitates an efficient sphincter-saving in patients with low rectal cancer. Int J Colorectal Dis 2017;32:1137–45.
48. Grass JK, Chen CC, Melling N, Lingala B, Kemper M, Scognamiglio P, et al. Robotic rectal resection preserves anorectal function: Systematic review and meta-analysis. Int J Med Robot 2021;17:e2329.
49. Roodbeen SX, Penna M, Mackenzie H, Kusters M, Slater A, Jones OM, et al. Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes. Surg Endosc 2019;33:2459–67.
50. Zuhdy M, Elmore U, Shams N, Hegazy M, Roshdy S, Eldamshety O, et al. Transanal versus laparoscopic total mesorectal excision: a comparative prospective clinical trial from two centers. J Laparoendosc Adv Surg Tech A 2020;30:769–76.
51. Lee JM, Han YD, Cho MS, Hur H, Min BS, Lee KY, et al. Prediction of transabdominal total mesorectal excision difficulty according to the angle of pelvic floor muscle. Surg Endosc 2020;34:3043–50.
52. Yasui M, Takemasa I, Miyake Y, Hata T, Ikeda M, Miyake Y, et al. Tumor Size as an independent risk factor for postoperative complications in laparoscopic low anterior resection for advanced rectal cancer: a multicenter Japanese study. Surg Laparosc Endosc Percutan Tech 2017;27:98–103.
54. Balciscueta Z, Uribe N, Caubet L, López M, Torrijo I, Tabet J, et al. Impact of the number of stapler firings on anastomotic leakage in laparoscopic rectal surgery: a systematic review and metaanalysis. Tech Coloproctol 2020;24:919–25.
55. Lacy AM, Tasende MM, Delgado S, Fernandez-Hevia M, Jimenez M, De Lacy B, et al. Transanal total mesorectal excision for rectal cancer: outcomes after 140 patients. J Am Coll Surg 2015;221:415–23.
56. Heald RJ. A new solution to some old problems: transanal TME. Tech Coloproctol 2013;17:257–8.
57. Motson RW, Whiteford MH, Hompes R, Albert M, Miles WF, Expert Group. Current status of trans-anal total mesorectal excision (TaTME) following the Second International Consensus Conference. Colorectal Dis 2016;18:13–8.
58. Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, et al. Incidence and risk factors for anastomotic failure in 1594 patients treated by transanal total mesorectal excision: results from the international TaTME Registry. Ann Surg 2019;269:700–11.
60. Sylla P, Knol JJ, D’Andrea AP, Perez RO, Atallah SB, Penna M, et al. Urethral injury and other urologic injuries during transanal total mesorectal excision: an international collaborative study. Ann Surg 2021;274:e115–25.
61. Dayal S, Moran B. LOREC: the English Low Rectal Cancer National Development Programme. Br J Hosp Med (Lond) 2013;74:377–80.
62. Persiani R, Agnes A, Belia F, D’Ugo D, Biondi A. The learning curve of TaTME for mid-low rectal cancer: a comprehensive analysis from a five-year institutional experience. Surg Endosc 2021;35:6190–200.
63. Larsen SG, Pfeffer F, Kørner H; Norwegian Colorectal Cancer Group. Norwegian moratorium on transanal total mesorectal excision. Br J Surg 2019;106:1120–1.
64. Wasmuth HH, Faerden AE, Myklebust TÅ, Pfeffer F, Norderval S, Riis R, et al. Transanal total mesorectal excision for rectal cancer has been suspended in Norway. Br J Surg 2020;107:121–30.
65. Deijen CL, Velthuis S, Tsai A, Mavroveli S, de Lange-de Klerk ES, Sietses C, et al. COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer. Surg Endosc 2016;30:3210–5.
66. van der Heijden J, van de Pas K, van den Broek F, van Dielen F, Slooter GD, Maaskant-Braat A. Oncological and functional outcomes of transanal total mesorectal excision in a teaching hospital in the Netherlands. Ann Coloproctol 2021 Jun 29 [Epub].
https://doi.org/10.3393/ac.2020.00773.0110
67. Balkarov AA, Alekseev MV, Rybakov EG, Frolov SA, Achkasov SI. Profilaktika nesostoyatel’nosti kolorektal’nogo anastomoza putem ego ukrepleniya (rezul’taty randomizirovannogo issledovaniya) [Prevention of colorectal anastomotic leakage using its reinforcement (results of the randomized study)]. Khirurgiia (Mosk) 2021;(7):18–23.
68. Alimova I, Chernyshov S, Nagudov M, Rybakov E. Comparison of oncological and functional outcomes and quality of life after transanal or laparoscopic total mesorectal excision for rectal cancer: a systematic review and meta-analysis. Tech Coloproctol 2021;25:901–13.
69. Kusters M, Marijnen CA, van de Velde CJ, Rutten HJ, Lahaye MJ, Kim JH, et al. Patterns of local recurrence in rectal cancer: a study of the Dutch TME trial. Eur J Surg Oncol 2010;36:470–6.
70. Park IJ, Kim JC. Adequate length of the distal resection margin in rectal cancer: from the oncological point of view. J Gastrointest Surg 2010;14:1331–7.
71. Kanso F, Lefevre JH, Svrcek M, Chafai N, Parc Y, Tiret E. Partial mesorectal excision for rectal adenocarcinoma: morbidity and oncological outcome. Clin Colorectal Cancer 2016;15:82–90.
72. Taylor FG, Quirke P, Heald RJ, Moran B, Blomqvist L, Swift I, et al. Preoperative high- resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg 2011;253:711–9.
74. Sauri F, Cho MS, Kim NK. Gate approach at deep anterolateral pelvic dissection. Surg Oncol 2021;37:101535.
75. Teramoto T, Watanabe M, Kitajima M. Per anum intersphincteric rectal dissection with direct coloanal anastomosis for lower rectal cancer: the ultimate sphincter-preserving operation. Dis Colon Rectum 1997;40(10 Suppl): S43–7.
76. Watanabe M, Teramoto T, Hasegawa H, Kitajima M. Laparoscopic ultralow anterior resection combined with per anum intersphincteric rectal dissection for lower rectal cancer. Dis Colon Rectum 2000;43(10 Suppl): S94–7.
77. Law WL, Chu KW. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients. Ann Surg 2004;240:260–8.
79. Nakagoe T, Ishikawa H, Sawai T, Tsuji T, Takeshita H, Nanashima A, et al. Oncological outcome of ultra-low anterior resection with total mesorectal excision for carcinoma of the lower third of the rectum: comparison of intrapelvic double-stapled anastomosis and transanal coloanal anastomosis. Hepatogastroenterology 2005;52:1692–7.
81. Kim HG, Kim HS, Yang SY, Han YD, Cho MS, Hur H, et al. Early recurrence after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: characteristics and risk factors. Asian J Surg 2021;44:298–302.
83. van der Valk M, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet 2018;391:2537–45.
84. Sauri F, Sakr A, Kim HS, Alessa M, Torky R, Zakarneh E, et al. Does the timing of protective ileostomy closure post-low anterior resection have an impact on the outcome? A retrospective study. Asian J Surg 2021;44:374–9.
85. Gavaruzzi T, Pace U, Giandomenico F, Pucciarelli S, Bianco F, Selvaggi F, et al. Colonic J-pouch or straight colorectal reconstruction after low anterior resection for rectal cancer: impact on quality of life and bowel function. A multicenter prospective randomized study. Dis Colon Rectum 2020;63:1511–23.
86. Baker JW. Low end to side rectosigmoidal anastomosis; description of technic. Arch Surg 1950;61:143–57.
87. Ziv Y, Zbar A, Bar-Shavit Y, Igov I. Low anterior resection syndrome (LARS): cause and effect and reconstructive considerations. Tech Coloproctol 2013;17:151–62.
88. Nakada I, Kawasaki S, Sonoda Y, Watanabe Y, Tabuchi T. Abdominal stapled side-to-end anastomosis (Baker type) in low and high anterior resection: experiences and results in 69 consecutive patients at a regional general hospital in Japan. Colorectal Dis 2004;6:165–70.
91. Sakr A, Yang SY, Kang JH, Cho MS, Han YD, Min BS, et al. Oncologic safety and bowel function after ultralow anterior resection with or without intersphincteric resection for low lying rectal cancer: comparative cross sectional study. J Surg Oncol 2019 Dec 3 [Epub].
https://doi.org/10.1002/jso.25791
92. Zhuang CL, Zhang FM, Wang Z, Jiang X, Wang F, Liu ZC. Precision functional sphincter-preserving surgery (PPS) for ultralow rectal cancer: a natural orifice specimen extraction (NOSE) surgery technique. Surg Endosc 2021;35:476–85.
93. Zhuang CL, Liu Z, Zhang FM, Wang Z, Liu Q, Liu ZC. Surgical key points of precision functional sphincter-preserving surgery. Zhonghua Wei Chang Wai Ke Za Zhi 2020;23:597–600.
94. Shang J, Leibrandt K, Giataganas P, Vitiello V, Seneci CA, Wisanuvej P, et al. A single-port robotic system for transanal microsurgery—design and validation. IEEE Robot Autom Lett 2017;2:1510–7.
95. Schiessel R, Karner-Hanusch J, Herbst F, Teleky B, Wunderlich M. Intersphincteric resection for low rectal tumours. Br J Surg 1994;81:1376–8.
96. Yamamoto S, Ito M, Okuda J, Fujii S, Yamaguchi S, Yoshimura K, et al. Laparoscopic surgery for stage 0/I rectal carcinoma: shortterm outcomes of a single-arm phase II trial. Ann Surg 2013;258:283–8.
97. Yamada K, Saiki Y, Takano S, Iwamoto K, Tanaka M, Fukunaga M, et al. Long-term results of intersphincteric resection for low rectal cancer in Japan. Surg Today 2019;49:275–85.
98. Fujimoto Y, Akiyoshi T, Kuroyanagi H, Konishi T, Ueno M, Oya M, et al. Safety and feasibility of laparoscopic intersphincteric resection for very low rectal cancer. J Gastrointest Surg 2010;14:645–50.
100. Akagi Y, Kinugasa T, Shirouzu K. Intersphincteric resection for very low rectal cancer: a systematic review. Surg Today 2013;43:838–47.
101. Rullier E, Sa Cunha A, Couderc P, Rullier A, Gontier R, Saric J. Laparoscopic intersphincteric resection with coloplasty and coloanal anastomosis for mid and low rectal cancer. Br J Surg 2003;90:445–51.
102. Kim NK, Kim YW, Cho MS. Intersphincteric resection and coloanal reconstruction. In: Chang G. editor. Rectal cancer: modern approaches to treatment. Singapore: Springer Cham; 2018. p.191–211.
103. Piozzi GN, Park H, Kim JS, Choi HB, Lee TH, Baek SJ, et al. Anatomic landmarks for transabdominal robotic-assisted intersphincteric dissection for ultralow anterior resection. Dis Colon Rectum 2021;64:e87–8.
104. Zhang B, Zhuo GZ, Zhao K, Zhao Y, Gao DW, Zhu J, et al. Cumulative incidence and risk factors of permanent stoma after intersphincteric resection for ultralow rectal cancer. Dis Colon Rectum 2022;65:66–75.
105. Narihiro S, Miura N, Nishizawa Y, Hasegawa H, Ikeda K, Teramura K, et al. Delorme surgery for colonic mucosal prolapse after intersphincteric resection. Surg Today 2021;51:916–22.
107. Chau A, Frasson M, Debove C, Maggiori L, Panis Y. Colonic prolapse after intersphincteric resection for very low rectal cancer: a report of 12 cases. Tech Coloproctol 2016;20:701–5.
108. Guraieb-Trueba M, Helber AR, Marks JH. Full-thickness neorectal prolapse after transanal transabdominal proctosigmoidectomy for low rectal cancer: a cohort study. Colorectal Dis 2018;20:593–6.
109. Denost Q, Moreau JB, Vendrely V, Celerier B, Rullier A, Assenat V, et al. Intersphincteric resection for low rectal cancer: the risk is functional rather than oncological. A 25-year experience from Bordeaux. Colorectal Dis 2020;22:1603–13.
110. Park JS, Kim NK, Kim SH, Lee KY, Lee KY, Shin JY, et al. Multicentre study of robotic intersphincteric resection for low rectal cancer. Br J Surg 2015;102:1567–73.
112. Kim NK, Sugihara K, Liang JT. Surgical treatment of colorectal cancer: Asian perspectives on optimization and standardization. Singapore: Springer Singapore; 2018.
113. Tsukada Y, Ito M, Watanabe K, Yamaguchi K, Kojima M, Hayashi R, et al. Topographic anatomy of the anal sphincter complex and levator ani muscle as it relates to intersphincteric resection for very low rectal disease. Dis Colon Rectum 2016;59:426–33.
115. Yang SY, Cho MS, Kim NK. Outcomes of robotic partial excision of the levator ani muscle for locally advanced low rectal cancer invading the ipsilateral pelvic floor at the anorectal ring level. Int J Med Robot 2021;17:e2310.
116. AlAsari SF, Lim D, Kim NK. Hemi-levator excision to provide greater sphincter preservation in low rectal cancer. Int J Colorectal Dis 2013;28:1727–8.
118. Shihab OC, Heald RJ, Holm T, How PD, Brown G, Quirke P, et al. A pictorial description of extralevator abdominoperineal excision for low rectal cancer. Colorectal Dis 2012;14:e655–60.
119. Campos FG, Habr-Gama A, Nahas SC, Perez RO. Abdominoperineal excision: evolution of a centenary operation. Dis Colon Rectum 2012;55:844–53.
120. de Campos-Lobato LF, Stocchi L, Dietz DW, Lavery IC, Fazio VW, Kalady MF. Prone or lithotomy positioning during an abdominoperineal resection for rectal cancer results in comparable oncologic outcomes. Dis Colon Rectum 2011;54:939–46.
124. Sabbagh C, Fumery M, Mauvais F, Regimbeau JM. The prone position for performing perineal dissection during extralevator abdominoperineal resection: a necessary waste of time? Dis Colon Rectum 2016;59:353–6.
125. Tao Y, Han JG, Wang ZJ. Comparison of perineal morbidity between biologic mesh reconstruction and primary closure following extralevator abdominoperineal excision: a systematic review and meta-analysis. Int J Colorectal Dis 2021;36:893–902.
126. Zaheer Ahmad N, Abbas MH, Al-Naimi N, Parvaiz A. Metaanalysis of biological mesh reconstruction versus primary perineal closure after abdominoperineal excision of rectal cancer. Int J Colorectal Dis 2021;36:477–92.
127. Meyer J, Roos E, Abbassi Z, Toso C, Ris F, Buchs NC. The role of perineal application of prophylactic negative-pressure wound therapy for prevention of wound-related complications after abdomino-perineal resection: a systematic review. Int J Colorectal Dis 2021;36:19–26.
128. Qi XY, Cui M, Liu MX, Xu K, Tan F, Yao ZD, et al. Extralevator abdominoperineal excision versus abdominoperineal excision for low rectal cancer: a meta-analysis. Chin Med J (Engl) 2019;132:2446–56.
129. Zhou X, Sun T, Xie H, Zhang Y, Zeng H, Fu W. Extralevator abdominoperineal excision for low rectal cancer: a systematic review and meta-analysis of the short-term outcome. Colorectal Dis 2015;17:474–81.
130. Habr-Gama A, São Julião GP, Mattacheo A, de Campos-Lobato LF, Aleman E, Vailati BB, et al. Extralevator abdominal perineal excision versus standard abdominal perineal excision: impact on quality of the resected specimen and postoperative morbidity. World J Surg 2017;41:2160–7.
133. West NP, Anderin C, Smith KJ, Holm T, QuirkeP P, European Extralevator Abdominoperineal Excision Study Group. Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg 2010;97:588–99.
134. Kasai S, Kagawa H, Shiomi A, Hino H, Manabe S, Yamaoka Y, et al. Advantages of robotic abdominoperineal resection compared with laparoscopic surgery: a single-center retrospective study. Surg Today 2021 Aug 21 [Epub].
https://doi.org/10.1007/s00595-021-02359-6
135. Matsuda T, Yamashita K, Hasegawa H, Takiguchi G, Urakawa N, Yamamoto M, et al. Transperineal minimally invasive abdominoperineal resection for low rectal cancer: standardized technique and clinical outcomes. Surg Endosc 2021;35:7236–45.
136. Emile SH, Elfeki H, Shalaby M, Sakr A, Kim NK. Outcome of lateral pelvic lymph node dissection with total mesorectal excision in treatment of rectal cancer: a systematic review and metaanalysis. Surgery 2021;169:1005–15.
137. Kroon HM, Malakorn S, Dudi-Venkata NN, Bedrikovetski S, Liu J, Kenyon-Smith T, et al. Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: an international multi-centre comparative study. Eur J Surg Oncol 2021;47:2441–9.
138. Ogura A, Konishi T, Cunningham C, Garcia-Aguilar J, Iversen H, Toda S, et al. Neoadjuvant (chemo)radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter lateral node study of patients with low cT3/4 rectal cancer. J Clin Oncol 2019;37:33–43.
140. Cribb B, Kong J, McCormick J, Warrier S, Heriot A. Meta-analysis of direct-to-surgery lateral pelvic lymph node dissection for rectal cancer. Colorectal Dis 2021;23:1687–98.
141. Fujita S, Yamamoto S, Akasu T, Moriya Y. Lateral pelvic lymph node dissection for advanced lower rectal cancer. Br J Surg 2003;90:1580–5.
142. Wang X, Qiu A, Liu X, Shi Y. Total mesorectal excision plus lateral lymph node dissection vs TME on rectal cancer patients: a meta-analysis. Int J Colorectal Dis 2020;35:997–1006.
143. Ito M, Kobayashi A, Fujita S, Mizusawa J, Kanemitsu Y, Kinugasa Y, et al. Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG0212). Eur J Surg Oncol 2018;44:463–8.
145. Fujita S, Akasu T, Mizusawa J, Saito N, Kinugasa Y, Kanemitsu Y, et al. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Lancet Oncol 2012;13:616–21.
146. Fujita S, Mizusawa J, Kanemitsu Y, Ito M, Kinugasa Y, Komori K, et al. Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled, noninferiority trial. Ann Surg 2017;266:201–7.
147. Kusters M, van de Velde CJ, Beets-Tan RG, Akasu T, Fujita S, Yamamoto S, et al. Patterns of local recurrence in rectal cancer: a single-center experience. Ann Surg Oncol 2009;16:289–96.
148. Akiyoshi T, Ueno M, Matsueda K, Konishi T, Fujimoto Y, Nagayama S, et al. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging. Ann Surg Oncol 2014;21:189–96.
149. Matsuda T, Sumi Y, Yamashita K, Hasegawa H, Yamamoto M, Matsuda Y, et al. Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Colorectal Dis 2018;33:367–74.
151. Steup WH, Moriya Y, van de Velde CJ. Patterns of lymphatic spread in rectal cancer. A topographical analysis on lymph node metastases. Eur J Cancer 2002;38:911–8.
153. Bae S, Kim NK. Is the never-ending story still unsolved? Beyond the long debate about lateral pelvic lymph node dissection in rectal cancer. Dis Colon Rectum 2021;64:253–5.
154. Kim HJ, Park JS, Choi GS, Park SY, Lee HJ. Fluorescence-guided robotic total mesorectal excision with lateral pelvic lymph node dissection in locally advanced rectal cancer: a video presentation. Dis Colon Rectum 2017;60:1332–3.
155. Shiratori H, Nozawa H, Kawai K, Hata K, Tanaka T, Kaneko M, et al. Risk factors and therapeutic significance of inguinal lymph node metastasis in advanced lower rectal cancer. Int J Colorectal Dis 2020;35:655–64.
156. Taylor N, Crane C, Skibber J, Feig B, Ellis L, Vauthey JN, et al. Elective groin irradiation is not indicated for patients with adenocarcinoma of the rectum extending to the anal canal. Int J Radiat Oncol Biol Phys 2001;51:741–7.
158. Habr-Gama A, Perez RO, Wynn G, Marks J, Kessler H, GamaRodrigues J. Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization. Dis Colon Rectum 2010;53:1692–8.
159. Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U Jr, Silva e Sousa AH Jr, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 2004;240:711–7.
160. Habr-Gama A, Gama-Rodrigues J, São Julião GP, Proscurshim I, Sabbagh C, Lynn PB, et al. Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. Int J Radiat Oncol Biol Phys 2014;88:822–8.
161. Hupkens B, Martens MH, Stoot JH, Berbee M, Melenhorst J, Beets-Tan RG, et al. Quality of life in rectal cancer patients after chemoradiation: watch-and-wait policy versus standard resection. A matched-controlled study. Dis Colon Rectum 2017;60:1032–40.
162. Beard BW, Rettig RL, Ryoo JJ, Parker RA, McLemore EC, Attaluri V. Watch-and-Wait compared to operation for patients with complete response to neoadjuvant therapy for rectal cancer. J Am Coll Surg 2020;231:681–92.
165. Appelt AL, Pløen J, Harling H, Jensen FS, Jensen LH, Jørgensen JC, et al. High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. Lancet Oncol 2015;16:919–27.
166. Maas M, Beets-Tan RG, Lambregts DM, Lammering G, Nelemans PJ, Engelen SM, et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 2011;29:4633–40.
167. Smith JD, Ruby JA, Goodman KA, Saltz LB, Guillem JG, Weiser MR, et al. Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy. Ann Surg 2012;256:965–72.
168. Habr-Gama A, São Julião GP, Gama-Rodrigues J, Vailati BB, Ortega C, Fernandez LM, et al. Baseline T classification predicts early tumor regrowth after nonoperative management in distal rectal cancer after extended neoadjuvant chemoradiation and initial complete clinical response. Dis Colon Rectum 2017;60:586–94.
169. Perez RO, Habr-Gama A, São Julião GP, Proscurshim I, Fernandez LM, de Azevedo RU, et al. Transanal endoscopic microsurgery (TEM) following neoadjuvant chemoradiation for rectal cancer: outcomes of salvage resection for local recurrence. Ann Surg Oncol 2016;23:1143–8.
170. Nasir I, Fernandez L, Vieira P, Parés O, Santiago I, Castillo-Martin M, et al. Salvage surgery for local regrowths in Watch & Wait: are we harming our patients by deferring the surgery? Eur J Surg Oncol 2019;45:1559–66.
171. Kong JC, Guerra GR, Warrier SK, Ramsay RG, Heriot AG. Outcome and salvage surgery following “watch and wait” for rectal cancer after neoadjuvant therapy: a systematic review. Dis Colon Rectum 2017;60:335–45.
173. Hiraki M, Tanaka T, Ikeda O, Sadashima E, Kimura N, Nakamura S, et al. Retrospective risk analysis for anastomotic leakage following laparoscopic rectal cancer surgery in a single institute. J Gastrointest Cancer 2020;51:908–13.
175. Dumble C, Morgan T, Wells CI, Bissett I, O’Grady G. The impact of transanal tube design for preventing anastomotic leak in anterior resection: a systematic review and meta-analysis. Tech Coloproctol 2021;25:59–68.
176. Choy KT, Yang T, Heriot A, Warrier SK, Kong JC. Does rectal tube/transanal stent placement after an anterior resection for rectal cancer reduce anastomotic leak? A systematic review and meta-analysis. Int J Colorectal Dis 2021;36:1123–32.
177. Armstrong G, Croft J, Corrigan N, Brown JM, Goh V, Quirke P, et al. IntAct: intra-operative fluorescence angiography to prevent anastomotic leak in rectal cancer surgery. A randomized controlled trial. Colorectal Dis 2018;20:O226–34.
178. Jarry J, Faucheron JL, Moreno W, Bellera CA, Evrard S. Delayed colo-anal anastomosis is an alternative to prophylactic diverting stoma after total mesorectal excision for middle and low rectal carcinomas. Eur J Surg Oncol 2011;37:127–33.
179. Portale G, Popesc GO, Parotto M, Cavallin F. Delayed colo-anal anastomosis for rectal cancer: pelvic morbidity, functional results and oncological outcomes. A systematic review. World J Surg 2019;43:1360–9.
182. Toh J, Matthews R, Kim SH. Arc of Riolan-preserving splenic flexure takedown during anterior resection: potentially critical to prevent acute anastomotic ischemia. Dis Colon Rectum 2018;61:411–4.